Author:
Järbe Torbjörn U. C.,LeMay Brian J.,Halikhedkar Aneetha,Wood JodiAnne,Vadivel Subramanian K.,Zvonok Alexander,Makriyannis Alexandros
Publisher
Springer Science and Business Media LLC
Reference71 articles.
1. Abadji V, Lin S, Taha G, Griffin G, Stevenson LA, Pertwee RG, Makriyannis A (1994) (R)-Methanandamide: a chiral novel anandamide possessing higher potency and metabolic stability. J Med Chem 37:1889–1893
2. Adams IB, Compton DR, Martin BR (1998) Assessment of anandamide interaction with the cannabinoid brain receptor: SR 141716A antagonism studies in mice and autoradiographic analysis of receptor binding in rat brain. J Pharmacol Exp Ther 284:1209–1217
3. Alici T, Appel JB (2004) Increasing the selectivity of the discriminative stimulus effects of delta-9-tetrahydrocannabinol: complete substitution with methanandamide. Pharmacol Biochem Behav 79:431–437
4. Bergman J, France CP, Holtzman SG, Katz JL, Koek W, Stephens DN (2000) Agonist efficacy, drug dependence, and medications development: preclinical evaluation of opioid, dopaminergic, and GABAA-ergic ligands. Psychopharmacol (Berl) 153:67–84
5. Bosier B, Muccioli GG, Hermans E, Lambert DM (2010) Functionally selective cannabinoid receptor signalling: therapeutic implications and opportunities. Biochem Pharmacol 80:1–12
Cited by
19 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献